7*24 Hotline：
Lepu (Beijing) medical device Co., Ltd. was established in 1999, which was jointly funded by the 725th Research Institute of China Shipbuilding Industry Corporation and WP company of the United States. The company is mainly engaged in the R & D, production and sales of coronary intervention medical devices. It is one of the few enterprises in the field of domestic high-end medical devices that can form a strong competition with foreign products. Since its establishment, the company has successively completed the R & D and industrialization of stents, catheters and other core interventional medical products. It is the first in the industry to obtain the product registration certificate (Class III) of "coronary stent delivery system" issued by the State Food and drug administration, the first to develop and trial produce the anti infection "drug central venous catheter", and the first in China to treat primary coronary artery disease Bioabsorbable stent for intravascular stenosis in patients with atherosclerosis [1].
On September 2, 2019, the Ministry of industry and information technology of the people's Republic of China issued the "public list of enterprises to be recognized as national technological innovation demonstration enterprises in 2019", and Lepu (Beijing) medical device Co., Ltd. was listed. [2]
oil wellhead